(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide


Chemical Name: (E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide
CAS Number: 929016-96-6
Product Number: AG00GTBP(AGN-PC-088RBM)
Synonyms:
MDL No:
Molecular Formula: C20H30N4O2
Molecular Weight: 358.4778

Identification/Properties


Computed Properties
Molecular Weight:
358.486g/mol
XLogP3:
3.1
Hydrogen Bond Donor Count:
2
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
10
Exact Mass:
358.237g/mol
Monoisotopic Mass:
358.237g/mol
Topological Polar Surface Area:
70.4A^2
Heavy Atom Count:
26
Formal Charge:
0
Complexity:
453
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Pracinostat is a potent histone deacetylase (HDAC) inhibitor that has found significant application in chemical synthesis, particularly in the field of medicinal chemistry. By inhibiting HDAC enzymes, Pracinostat can modulate gene expression and protein function, offering a valuable tool for researchers looking to study epigenetic mechanisms.One key application of Pracinostat in chemical synthesis is its role in the development of new pharmaceutical compounds. The ability of Pracinostat to specifically target and modify histone acetylation patterns allows researchers to investigate the impact of epigenetic changes on disease states. This knowledge can then be leveraged to design novel therapeutic agents that target specific pathways involved in various medical conditions.Furthermore, Pracinostat's ability to alter gene expression profiles can be utilized in the synthesis of custom biomolecules and peptides. By regulating the acetylation status of histones, researchers can manipulate the transcription of genes involved in peptide synthesis, leading to the production of tailored biomolecules with desired properties.Overall, Pracinostat's unique mechanism of action as an HDAC inhibitor makes it a valuable tool in chemical synthesis for studying epigenetic processes, developing new pharmaceuticals, and creating customized biomolecules for various applications in research and drug development.